Leerink Partnrs Issues Negative Outlook for PRCT Earnings
PROCEPT BioRobotics Co. (NASDAQ:PRCT – Free Report) – Equities researchers at Leerink Partnrs reduced their Q2 2025 earnings per share estimates for shares of PROCEPT BioRobotics in a research note issued on Monday, April 28th. Leerink Partnrs analyst M. Kratky now expects that the company will earn ($0.43) per share for the quarter, down from […]
